141 related articles for article (PubMed ID: 34342078)
21. Multicentre phase II study of cisplatin-etoposide chemotherapy for advanced large-cell neuroendocrine lung carcinoma: the GFPC 0302 study.
Le Treut J; Sault MC; Lena H; Souquet PJ; Vergnenegre A; Le Caer H; Berard H; Boffa S; Monnet I; Damotte D; Chouaid C
Ann Oncol; 2013 Jun; 24(6):1548-52. PubMed ID: 23406729
[TBL] [Abstract][Full Text] [Related]
22. Primary large cell neuroendocrine carcinoma of the prostate in a hormone naive patient: A case report from Taiwan.
Tzou KY; Cheng WH; Lee WH; Ho CH
J Cancer Res Ther; 2018 Sep; 14(Supplement):S785-S788. PubMed ID: 30249904
[TBL] [Abstract][Full Text] [Related]
23. A Phase III trial comparing irinotecan and cisplatin with etoposide and cisplatin in adjuvant chemotherapy for completely resected pulmonary high-grade neuroendocrine carcinoma (JCOG1205/1206).
Eba J; Kenmotsu H; Tsuboi M; Niho S; Katayama H; Shibata T; Watanabe S; Yamamoto N; Tamura T; Asamura H; ;
Jpn J Clin Oncol; 2014 Apr; 44(4):379-82. PubMed ID: 24474818
[TBL] [Abstract][Full Text] [Related]
24. Flushing as atypical initial presentation of functional gallbladder neuroendocrine carcinoma: A case report.
Jin M; Zhou B; Jiang XL; Zhang QY; Zheng X; Jiang YC; Yan S
World J Gastroenterol; 2020 Feb; 26(6):686-695. PubMed ID: 32103876
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and Safety of Carboplatin and Etoposide Combination Chemotherapy for Extrapulmonary Neuroendocrine Carcinoma: A Retrospective Case Series.
Imai H; Shirota H; Okita A; Komine K; Saijo K; Takahashi M; Takahashi S; Takahashi M; Shimodaira H; Ishioka C
Chemotherapy; 2016; 61(3):111-6. PubMed ID: 26636658
[TBL] [Abstract][Full Text] [Related]
26. Successful treatment of esthesioneuroblastoma and neuroendocrine carcinoma with combined chemotherapy and proton radiation. Results in 9 cases.
Bhattacharyya N; Thornton AF; Joseph MP; Goodman ML; Amrein PC
Arch Otolaryngol Head Neck Surg; 1997 Jan; 123(1):34-40. PubMed ID: 9006501
[TBL] [Abstract][Full Text] [Related]
27. Long Non-coding RNAs in Pulmonary Neuroendocrine Neoplasms.
Narayanan D; Mandal R; Hardin H; Chanana V; Schwalbe M; Rosenbaum J; Buehler D; Lloyd RV
Endocr Pathol; 2020 Sep; 31(3):254-263. PubMed ID: 32388776
[TBL] [Abstract][Full Text] [Related]
28. A retrospective study of definitive chemoradiotherapy in patients with resectable small cell neuroendocrine carcinoma of the esophagus.
Katada C; Komori S; Yoshida T; Kawakami S; Watanabe A; Ishido K; Azuma M; Wada T; Hosoda K; Yamashita K; Hiki N; Tanabe S; Ishiyama H; Koizumi W
Esophagus; 2020 Apr; 17(2):135-140. PubMed ID: 31321580
[TBL] [Abstract][Full Text] [Related]
29. Advances in the Diagnosis and Management of Well-Differentiated and Intermediate-Differentiated Neuroendocrine Tumors of the Lung.
Wolin EM
Chest; 2017 May; 151(5):1141-1146. PubMed ID: 27373769
[TBL] [Abstract][Full Text] [Related]
30. Primary small cell neuroendocrine carcinoma of the tonsil: a case report and review of the literature.
Wang HY; Zou J; Zhou GY; Yan JQ; Liu SX
Int J Clin Exp Pathol; 2014; 7(5):2678-82. PubMed ID: 24966986
[TBL] [Abstract][Full Text] [Related]
31. Neuroendocrine carcinoma of the nasopharynx in a dog.
Patnaik AK; Ludwig LL; Erlandson RA
Vet Pathol; 2002 Jul; 39(4):496-500. PubMed ID: 12126154
[TBL] [Abstract][Full Text] [Related]
32. Primary neuroendocrine carcinoma of the breast.
Bergstrom C; Porembka J; Fang Y; Sarode V; Syed S
Breast J; 2019 May; 25(3):519-520. PubMed ID: 31001910
[No Abstract] [Full Text] [Related]
33. Postirradiated neuroendocrine carcinoma of the sinonasal tract.
Wang CP; Hsieh CY; Chang YL; Lou PJ; Yang TL; Ting LL; Ko JY
Laryngoscope; 2008 May; 118(5):804-9. PubMed ID: 18520182
[TBL] [Abstract][Full Text] [Related]
34. Small-cell neuroendocrine carcinoma originating from the lateral nasopharyngeal wall.
Deviprasad S; Rajeshwari A; Tahir M; Adarsha TV; Gangadhara S
Ear Nose Throat J; 2008 Nov; 87(11):E1-3. PubMed ID: 19006052
[TBL] [Abstract][Full Text] [Related]
35. Heterogeneity of grade 3 gastroenteropancreatic neuroendocrine carcinomas: New insights and treatment implications.
Fazio N; Milione M
Cancer Treat Rev; 2016 Nov; 50():61-67. PubMed ID: 27636009
[TBL] [Abstract][Full Text] [Related]
36. Small Cell Neuroendocrine of the Head and Neck: A Rare Presentation and Review of the Literature.
Niforatos S; Sandhu M; Kallem M; Serinelli S; Curtiss C; Akhtar K
J Investig Med High Impact Case Rep; 2022; 10():23247096221127792. PubMed ID: 36165297
[TBL] [Abstract][Full Text] [Related]
37. Good performance of platinum-based chemotherapy for high-grade gastroenteropancreatic and unknown primary neuroendocrine neoplasms.
Brandi G; Paragona M; Campana D; Brighi N; Bondi A; Pantaleo MA; Corbelli J; Barbera MA; Biasco G
J Chemother; 2018 Feb; 30(1):53-58. PubMed ID: 28641483
[TBL] [Abstract][Full Text] [Related]
38. Pathological and genomic phenotype of second neuroendocrine carcinoma during long-term follow-up after radical radiotherapy for nasopharyngeal carcinoma.
Peng YP; Liu QD; Lin YJ; Peng SL; Wang R; Xu XW; Wei W; Zhong GH; Zhou YL; Zhang YQ; Liu Y; Wang SY; Hong HY; Liu ZG
Radiat Oncol; 2021 Oct; 16(1):198. PubMed ID: 34635145
[TBL] [Abstract][Full Text] [Related]
39. The classification of neuroendocrine neoplasms of the breast and its clinical relevance.
Uccella S
Virchows Arch; 2022 Jul; 481(1):3-12. PubMed ID: 34698887
[TBL] [Abstract][Full Text] [Related]
40. Small-cell neuroendocrine carcinoma of the ileum: case report and literature review.
Lee JE; Hong SH; Jung HI; Son MW; Ahn TS; Han SW; Cho JH
BMC Surg; 2019 Sep; 19(1):135. PubMed ID: 31510991
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
